BCRX

#1599
BioCryst Pharmaceuticals, Inc. - Common Stock
8.9 1 USD
-1.87%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
8.91
8.91
Faixa anual
6.00
11.31
Mudança diária
-1.87%
Mudança mensal
-1.11%
Mudança em 6 meses
+25.85%
Mudança anual
-17.88%
Fechamento anterior
9.0 8
Open
8.9 1
Mínimo
8.9 1
High
8.9 1
Volume
277
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 2.26 B
  • Employee 435
  • Founded 1986
  • CEO Jon P. Stonehouse
  • Website www.biocryst.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLYWX6
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
6.45
Índice preço/fluxo de caixa
1.95

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

Notícias